Related Experiment Videos
Leuprolide acetate-induced dermatitis herpetiformis.
Ronald E Grimwood1, Adrian Guevara
1Division of Dermatology, University of Texas Health Science Center at San Antonio, TX 78229-3900, USA. grimwood@uthscsa.edu
Cutis
|March 1, 2005
Summary
Dermatitis herpetiformis, a skin condition, can be triggered by medications. This case study highlights leuprolide acetate injections as a potential cause of this autoimmune disorder.
Area of Science:
- Dermatology
- Immunology
- Endocrinology
Background:
- Dermatitis herpetiformis (DH) is a chronic, itchy skin condition.
- It is characterized by specific immune system responses in the skin.
- Gluten intake is a known factor influencing DH severity.
Observation:
- A patient with prostate cancer received leuprolide acetate injections.
- The patient developed dermatitis herpetiformis following these injections.
- Leuprolide acetate is a gonadotropin-releasing hormone analog.
Findings:
- This report details a rare instance of drug-induced dermatitis herpetiformis.
- Leuprolide acetate was identified as the likely trigger for DH in this patient.
- The case demonstrates a novel association between this medication and DH.
Implications:
- This finding expands the list of potential drug triggers for dermatitis herpetiformis.
- Clinicians should consider leuprolide acetate when diagnosing drug-induced DH.
- Further research may explore the mechanisms linking GnRH analogs to DH pathogenesis.